HSA | FSA CARDS ARE NOW ACCEPTED

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on hormones and fertility. Browse all Hormones & Fertility education

When you see "genetic testing for sexual health," you might imagine a single gene test — NOS3, perhaps, or a testosterone metabolism variant. What the PlexusDx Precision Peptide Genetic Test delivers is structurally different. It organizes genetic analysis into 14 pathways — biologically related gene clusters analyzed as connected systems rather than isolated variants. The Sexual Health pathway is one of those 14, and it delivers 6 insights that together map the complete genetic architecture of sexual arousal, desire, bonding, vascular response, and circadian timing. Understanding what those 6 insights are, why they're grouped as a pathway, and how the pathway connects to the broader 14 pathways, 49 peptides, and 150+ genetic insights of the full panel is what this post explains.

What a "Pathway" Means in Genetic Testing

Most consumer genetic tests report individual variants in isolation: one gene, one result, one conclusion. A single-gene sexual health test might tell you your NOS3 Glu298Asp genotype. But NOS3's functional sexual health impact depends on whether MC4R is generating adequate central arousal to activate eNOS in the first place, whether DRD2 is sustaining the motivational desire drive that keeps that arousal going, whether OXTR is amplifying arousal through bonding-linked eNOS activation during intimacy, and whether MTNR1B is keeping the circadian system synchronized so that testosterone, autonomic tone, and hypothalamic responsiveness are aligned to peak sexual function windows.

A pathway test asks a fundamentally different question: not "what does this gene do?" but "how do the genes that regulate this biological system interact — and what does the combined variant pattern across them reveal?" For sexual health, that question produces a six-gene picture that no single-variant test can approach. The pathway structure is precisely why the 6 Sexual Health insights are more clinically useful than any subset of them analyzed alone.

The Six Insights in the Sexual Health Pathway

Insight 1 — eNOS / NOS3: The Vascular NO Production Baseline

NOS3 encodes endothelial nitric oxide synthase — the enzyme producing the nitric oxide (NO) that drives smooth muscle relaxation and genital engorgement in both men and women. Three functional variants shape this baseline: Glu298Asp (rs1799983), which affects eNOS protein stability and cleavage; T-786C (rs2070744), which affects NOS3 promoter transcription rate; and the intron 4 VNTR (4a/4b), which affects NOS3 mRNA levels. Together these three variants determine the endothelial NO production capacity that the entire vascular sexual response — and PDE5 pathway support — depends on. NOS3 is the first and foundational insight in the Sexual Health pathway: it sets the vascular floor that every downstream approach operates from. Full detail: eNOS (NOS3) and Nitric Oxide Genetics.

Insight 2 — Melanocortin Pathway / MC4R: The Central Arousal Signal

MC4R (melanocortin receptor 4) is the hypothalamic receptor through which α-MSH generates the central arousal signal that initiates the entire peripheral sexual response cascade. Expressed densely in the paraventricular nucleus (PVN) and medial preoptic area (MPOA), MC4R activation by α-MSH fires the descending parasympathetic signal that activates both neuronal nNOS in parasympathetic nerve terminals and endothelial eNOS in genital vasculature. MC4R variants — including rs17782313 (near MC4R) and rare coding variants — that reduce receptor expression or Gs coupling efficiency attenuate this central signal before it reaches the vasculature. MC4R is the central arousal insight in the Sexual Health pathway: it determines whether adequate brain-level arousal signal exists to drive the peripheral systems. Full detail: The Melanocortin Pathway: Genetics of Central Sexual Response.

Insight 3 — DRD2: The Motivational Desire Architecture

DRD2 encodes dopamine receptor D2 — the primary autoreceptor governing mesolimbic reward system sensitivity. The Taq1A variant (rs1800497) A1 allele is associated with approximately 30–40% lower striatal D2 receptor density, producing a reward system that generates less motivational salience from sexual stimuli, habituates faster in familiar contexts, and is more susceptible to stress-induced desire suppression. DRD2 is the desire and motivation insight in the Sexual Health pathway: it determines the neurochemical intensity of the motivational drive toward sexual activity — the "wanting" dimension of desire that is entirely distinct from the vascular and arousal dimensions below it. Full detail: DRD2 Dopamine Receptor and Desire Pathways.

Insight 4 — OXTR: Bonding, Arousal Facilitation, and Vascular Augmentation

OXTR encodes the oxytocin receptor — the seven-transmembrane GPCR through which oxytocin mediates bonding reinforcement, arousal amplification, and direct vascular eNOS activation. The rs53576 variant (G/A in intron 3) is the most studied OXTR SNP for social and arousal behavior: G/G genotype is associated with higher central oxytocin receptor sensitivity, stronger nucleus accumbens dopaminergic arousal amplification from oxytocin release, and more potent OXTR-mediated eNOS phosphorylation in vascular endothelium during physical intimacy. OXTR is the bonding and arousal facilitation insight in the Sexual Health pathway: it shapes the relational and physical intimacy dimensions of arousal that neither vascular NOS3 genetics nor central MC4R genetics capture. Full detail: OXTR Oxytocin Receptor Genetics.

Insight 5 — MTNR1B: The Circadian Architecture of Sexual Function

MTNR1B encodes melatonin receptor 1B (MT2) — the high-affinity melatonin receptor governing circadian regulation of the reproductive axis, autonomic tone, and hypothalamic arousal responsiveness. MTNR1B variants alter MT2 sensitivity to the nightly melatonin signal that synchronizes testosterone rhythmicity, parasympathetic peak windows, and the circadian active-phase alignment of hypothalamic arousal circuits. The most studied variant is rs10830963 (Ile49Thr G allele), associated with enhanced melatonin signaling and circadian metabolic effects. MTNR1B is the circadian insight in the Sexual Health pathway: it determines the precision with which the body's peak sexual response windows — morning testosterone, parasympathetic dominance, hypothalamic arousal responsiveness — are synchronized to waking activity hours. Full detail: MTNR1B and Circadian Sexual Function.

Insight 6 — Vasoactive Pathway Genetics: The Full Vascular Architecture

The sixth insight in the Sexual Health pathway extends beyond the primary NOS3 nitric oxide system to capture the complete vasoactive architecture of sexual response — including the prostaglandin pathway (PTGIS/PTGER variants that shape cAMP-mediated parallel vasodilation), alpha-adrenergic tone (ADRA1A variants that shape the sympathetic vasoconstrictor opposition to arousal-driven vasodilation), and Rho-kinase pathway (ROCK1/ROCK2 variants that shape the calcium-sensitization contractile baseline in genital smooth muscle). This insight completes the vascular picture by mapping the parallel and opposing systems that determine what the NOS3 baseline eNOS activity can actually achieve in genital vasculature. Full detail: Vasoactive Pathway Genetics for Sexual Health.

How the Six Insights Work as a Connected System

The six Sexual Health insights do not operate in parallel — they operate in functional sequence, with each insight conditioning the biological context that the next insight operates in:

MTNR1B governs the circadian timing precision of all downstream systems — whether testosterone, autonomic balance, and hypothalamic responsiveness are aligned to produce peak sexual function during waking activity hours. Circadian disruption from MTNR1B variants reduces the performance of every downstream system simultaneously.

DRD2 generates the dopaminergic motivational drive that initiates sexual pursuit and sustains the arousal-seeking engagement that activates the central arousal cascade. DRD2 is also the upstream driver of α-MSH release from arcuate nucleus POMC neurons — making dopaminergic tone a direct determinant of MC4R signal intensity.

MC4R receives the α-MSH signal driven by dopaminergic input and generates the descending hypothalamic arousal signal that activates penile and clitoral parasympathetic vasculature. MC4R also triggers oxytocinergic neuron firing — connecting central arousal to the OXTR-mediated peripheral response.

OXTR receives the MC4R-triggered oxytocin signal and simultaneously amplifies DRD2-mediated nucleus accumbens dopamine (increasing desire intensity from bonding context) and activates endothelial eNOS phosphorylation (contributing to peripheral NO production alongside neural arousal signals). OXTR is the bridge between central arousal and peripheral vascular response.

NOS3 receives the combined neural and OXTR-mediated eNOS activation signals and determines how much NO — and therefore how much cGMP — is produced in genital smooth muscle. NOS3 genotype sets the vascular execution capacity of whatever central and bonding arousal signals the upstream pathway has generated.

Vasoactive pathway completes the picture: prostaglandin pathway variants determine whether parallel cAMP-mediated vasodilation supplements the NOS3 NO signal; ADRA1A variants determine how much sympathetic vasoconstriction opposes it; ROCK variants determine the Rho-kinase contractile baseline that vasodilation must overcome. Together these three systems define the full vascular response architecture that NOS3 NO production operates within.

No single insight tells the complete Sexual Health story. The pathway structure captures the interactions that isolated gene testing cannot — which is why the Sexual Health pathway is built around six insights analyzed as a system rather than six independent data points.

How the Sexual Health Pathway Connects to the Other 13 Pathways

The Sexual Health pathway shares several genetic variables with other pathways in the 14-pathway panel — connections that surface cross-pathway interactions invisible to single-pathway analysis:

Mood (8 insights): DRD2 and COMT appear in both Sexual Health and Mood pathways. DRD2 governs dopaminergic desire in sexual contexts and dopaminergic reward processing in mood and motivation contexts simultaneously. COMT governs catecholamine clearance in both prefrontal cognitive-emotional function and sexual desire dopamine metabolism — making COMT genetics relevant to both sexual desire and emotional resilience in ways that a single-pathway test cannot surface.

Reproductive Health (6 insights, men's panel): The men's Reproductive Health pathway covers testosterone production, metabolism, SHBG binding, and androgen receptor sensitivity — the hormonal foundation that supports eNOS expression and hypothalamic arousal circuit priming that the Sexual Health pathway genes operate within. Testosterone provides the androgenic environment; Sexual Health pathway genes determine what that environment drives.

Longevity & Aging (17 insights): NOS3 eNOS function is one of the most potent determinants of vascular endothelial health across all ages and tissue types — not just in genital vasculature. The NOS3 variants relevant to sexual response are the same variants relevant to cardiovascular health, cognitive function, and longevity-associated vascular aging. Understanding NOS3 in the Sexual Health context reveals a variable with health implications that extend far beyond sexual function.

Sleep (3 insights): MTNR1B appears in both the Sexual Health and Sleep pathways. Its MT2 receptor function governs both the circadian timing of testosterone and sexual arousal peaks and the quality of sleep architecture — making MTNR1B genetics a shared driver of sexual wellness and sleep health simultaneously.

These cross-pathway connections are part of what makes a 14-pathway panel more informative than a focused single-pathway test — the same variant contributes to multiple pathway pictures simultaneously, and the system-level view surfaces those interactions for the complete clinical picture.

What the Sexual Health Pathway Results Reveal

Results from the 6 Sexual Health insights are delivered through the secure PlexusDx Results Portal, generated from the Illumina Global Screening Array at CLIA-certified labs, covering 57 unique SNPs across 48 unique genes in the full panel. Each insight is paired with pathway context — explaining the variant's functional role, how it interacts with adjacent insights in the pathway, and what the result means in terms of biological tendency rather than diagnosis or prescription.

The Sexual Health pathway results sit within the broader 14-pathway report — alongside Longevity & Aging, Mood, Reproductive Health, Sleep, and the other pathways that together comprise the full 150+ genetic insights the Precision Peptide Genetic Test delivers. The complete framework for the Sexual Health panel — how the 6 insights work together and what the full report covers — is in the Complete Guide to Genetic Sexual Health Testing. How these six insights specifically explain why PDE5 pathway response varies is in Why Do PDE5 Medications Work Differently? and PDE5 Pathway Genetics: Why Response Varies.

The Precision Peptide Genetic Test analyzes how your genes influence sexual health and related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

Ready to see your complete Sexual Health pathway profile? Take the Precision Peptide Genetic Test

Frequently Asked Questions About the Sexual Health Pathway

How many insights does the Sexual Health pathway contain?

The Sexual Health pathway delivers 6 insights: NOS3 (eNOS vascular NO baseline), MC4R (melanocortin central arousal), DRD2 (dopamine desire and motivation), OXTR (oxytocin bonding and arousal facilitation), MTNR1B (circadian sexual timing), and vasoactive pathway genetics. All six sit within 14 total pathways and 150+ genetic insights from the Precision Peptide Genetic Test.

How is a pathway different from a single-gene sexual health test?

Single-gene tests return results in isolation. The Sexual Health pathway analyzes six genes as a system — NOS3 vascular response depends on MC4R arousal; MC4R depends on DRD2 dopaminergic input; OXTR augments NOS3 eNOS; MTNR1B governs circadian context. Reading genes alone misses these interactions. The Precision Peptide Genetic Test maps all six within 14 pathways.

Are Sexual Health pathway results actionable without a provider?

Results reveal genetic tendencies — not diagnoses or prescriptions — and are designed to be shared with a qualified provider alongside symptoms, hormone levels, and sleep quality. The Precision Peptide Genetic Test delivers the genetic layer that bloodwork cannot, within 6 Sexual Health insights, 14 pathways, and 150+ genetic insights, to inform the clinical conversation.

This article is part of the PlexusDx Education Hub. Browse all Hormones & Fertility education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.